Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
21.06 USD | -0.31% | -3.24% | -12.23% |
05-14 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
05-10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.23% | 6.15B | |
+7.63% | 113B | |
+10.98% | 106B | |
+0.41% | 22.27B | |
-11.88% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-6.04% | 17.24B | |
+6.76% | 14.29B | |
+36.15% | 12.52B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Transcript : Exelixis, Inc. - Shareholder/Analyst Call